ask="N/A"
ask_size="N/A"
average_daily_volume="146526"
bid="N/A"
bid_size="N/A"
book_value="6.55"
change="N/A"
change_from_200_day_moving_average="1.04"
change_from_50_day_moving_average="-0.04"
change_from_52_week_high="-2.86"
change_From_52_week_low="4.62"
change_in_percent="N/A"
close="16.64"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.68"
ebitda="-63.46M"
eps_estimate_current_year="-3.02"
eps_estimate_next_quarter="-0.73"
eps_estimate_next_year="-3.05"
ex_dividend_date="N/A"
float_shares="11633000"
high="N/A"
high_52_weeks="19.50"
last_trade_date="2/13/2017"
last_trade_price="16.64"
last_trade_size="N/A"
last_trade_time="4:00pm"
low="N/A"
low_52_weeks="12.02"
market_capitalization="365.78M"
moving_average_200_day="15.60"
moving_average_50_day="16.68"
name="Adamas Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="30.67"
open="N/A"
pe_ratio="N/A"
peg_ratio="-0.07"
percent_change_from_200_day_moving_average="+6.67%"
percent_change_from_50_day_moving_average="-0.22%"
percent_change_from_52_week_high="-14.67%"
percent_change_from_52_week_low="+38.44%"
previous_close="16.64"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.54"
price_per_sales="345.40"
revenue="1.06M"
shares_outstanding="21982000"
short_ratio="19.33"
stock_exchange="NGM"
symbol="ADMS"
volume="0"
weeks_range_52="12.02 - 19.50"
